Implications of differential age distribution of disease-associated meningococcal lineages for vaccine development

Clinical and Vaccine Immunology

Volumn 21, Issue 6, 2014, Pages 847-853

  Brehony, Carina ^a   Trotter, Caroline L ^b   Ramsay, Mary E ^c   Chandra, Manosree ^c   Jolley, Keith A ^a   Van Der Ende, Arie ^d   Carion, Françoise ^e   Berthelsen, Lene ^f   Hoffmann, Steen ^f   Haroardóttir, Hjördís ^g   Vazquez, Julio A ^h   Murphy, Karen ⁱ   Toropainen, Maija ^j   Caniça, Manuela ^k   Ferreira, Eugenia ^k   Diggle, Mathew ^l   Edwards, Giles F ^l   Taha, Muhamed Kheir ^m   Stefanelli, Paola ⁿ   Kriz, Paula ^o   Gray, Steve J ^p   Fox, Andrew J ^p   Jacobsson, Susanne ^q   Claus, Heike ^r   Vogel, Ulrich ^r   Tzanakaki, Georgina ^s   Heuberger, Sigrid ^t   Caugant, Dominique A ^u   Frosch, Matthias ^r   Maiden, Martin C J ^a   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^f STATENS SERUM INSTITUT   (Denmark)

^g LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^h Meningococcal Reference Laboratory   (Spain)

ⁱ Irish Meningococcal and Meningitis Reference Laboratory   (Ireland)

^j NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^k NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^l Scottish Haemophilus Legionella Meningococcus and Pneumococcus Reference Laboratory ^*  (United Kingdom)

^m INSTITUT PASTEUR   (France)

ⁿ ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^o NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^p MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^q ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^r UNIVERSITY OF WÜRZBURG   (Germany)

^s NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^t National Reference Centre for Meningococci   (Austria)

^u NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BACTERIUM ISOLATE; CHILD; DISEASE ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; NONHUMAN; PRESCHOOL CHILD; PREVENTION AND CONTROL; PRIORITY JOURNAL; RISK ASSESSMENT; VACCINE PRODUCTION; YOUNG ADULT; BACTERIAL CAPSULE; DNA SEQUENCE; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; MENINGITIS, MENINGOCOCCAL; MICROBIOLOGY; NUCLEOTIDE SEQUENCE;

BACTERIAL ANTIGEN; CAPSULAR POLYSACCHARIDE, MENINGOCOCCAL GROUP B; MENINGOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIGENS, BACTERIAL; BACTERIAL CAPSULES; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; NEISSERIA MENINGITIDIS, SEROGROUP B; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84901633276     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00133-14     Document Type: Article

References (52)

1. Stephens DS, Greenwood B, Brandtzaeg P. 2007. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369:2196-2210. http://dx.doi.org/10.1016/S0140-6736(07)61016-2. (Pubitemid 46977462)
2. Edmond K, Clark AJ, Korczak VS, Sanderson C, Griffiths UK, Rudan I. 2010. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect. Dis. 10:317-328. http://dx.doi.org/10.1016/S1473-3099(10)70048-7.
3. Halperin SA, Bettinger JA, Greenwood B, Harrison LH, Jelfs J, Ladhani SN, McIntyre P, Ramsay ME, Sáfadi MAP. 2012. The changing and dynamic epidemiology of meningococcal disease. Vaccine 30(Suppl 2):B26-B36. http://dx.doi.org/10.1016/j.vaccine.2011.12.032.
4. Broome CV. 1986. The carrier state: Neisseria meningitidis. J. Antimicrob. Chemother. 18(Suppl A):25-34. (Pubitemid 16038220)
5. Cartwright K (ed). 1995. Meningococcal disease. John Wiley & Sons, Chichester, United Kingdom.
6. Maiden MC. 2004. Dynamics of bacterial carriage and disease: lessons from the meningococcus. Adv. Exp. Med. Biol. 549:23-29. http://dx.doi.org/10.1007/ 978-1-4419-8993-2-5. (Pubitemid 38968176)
7. Christensen H, May M, Bowen L, Hickman M, Trotter CL. 2010. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect. Dis. 10:853-861. http://dx.doi.org/10.1016/S1473-3099(10)70251-6.
8. Caugant DA, Høiby EA, Magnus P, Scheel O, Hoel T, Bjune G, Wedege E, Eng J, Frøholm LO. 1994. Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J. Clin. Microbiol. 32:323-330. (Pubitemid 24033891)
9. Bogaert D, Hermans PW, Boelens H, Sluijter M, Luijendijk A, Rumke HC, Koppen S, van Belkum A, de Groot R, Verbrugh HA. 2005. Epidemiology of nasopharyngeal carriage of Neisseria meningitidis in healthy Dutch children. Clin. Infect. Dis. 40:899-902. http://dx.doi.org/10.1086/428351. (Pubitemid 40365516)
10. Claus H, Maiden MC, Wilson DJ, McCarthy ND, Jolley KA, Urwin R, Hessler F, Frosch M, Vogel U. 2005. Genetic analysis of meningococci carried by children and young adults. J. Infect. Dis. 191:1263-1271. http://dx.doi.org/10.1086/ 428590.
11. Whitney AM, Coulson GB, von Gottberg A, Block C, Keller N, Mayer LW, Messonnier NE, Klugman KP. 2009. Genotypic comparison of invasive Neisseria meningitidis serogroup Y isolates from the United States, South Africa, and Israel, isolated from 1999 through 2002. J. Clin. Microbiol. 47:2787-2793. http://dx.doi.org/10.1128/JCM.00091-09.
12. Harrison OB, Claus H, Jiang Y, Bennett JS, Bratcher HB, Jolley KA, Corton C, Care R, Poolman JT, Zollinger WD, Frasch CE, Stephens DS, Feavers I, Frosch M, Parkhill J, Vogel U, Quail MA, Bentley SD, Maiden MCJ. 2013. Description and nomenclature of Neisseria meningitidis capsule locus. Emerg. Infect. Dis. 19:566-573. http://dx.doi.org/10.3201/eid1904.111799.
13. Harrison LH, Trotter CL, Ramsay ME. 2009. Global epidemiology of meningococcal disease. Vaccine 27:B51-B63. http://dx.doi.org/10.1016/j.vaccine. 2009.04.063.
14. Caugant DA, Kristiansen PA, Wang X, Mayer LW, Taha MK, Ouedraogo R, Kandolo D, Bougoudogo F, Sow S, Bonte L. 2012. Molecular characterization of invasive meningococcal isolates from countries in the African Meningitis Belt before introduction of a serogroup A conjugate vaccine. PLoS One 7:e46019. http://dx.doi.org/10.1371/journal.pone.0046019.
15. Bettinger JA, Scheifele DW, Le Saux N, Halperin SA, Vaudry W, Tsang R. 2013. The disease burden of invasive meningococcal serogroup B disease in Canada. Pediatr. Infect. Dis. J. 32:e20-e25. http://dx.doi.org/10.1097/INF. 0b013e3182706b89.
16. Ibarz-Pavón AB, Lemos AP, Gorla MC, Regueira M, SIREVA Working Group II, Gabastou JM. 2012. Laboratory-based surveillance of Neisseria meningitidis isolates from disease cases in Latin American and Caribbean countries, SIREVA II 2006-2010. PLoS One 7:e44102. http://dx.doi.org/10.1371/ journal.pone.0044102.
17. McEllistrem MC, Kolano JA, Pass MA, Caugant DA, Mendelsohn AB, Fonseca Pacheco AG, Shutt KA, Razeq J, Harrison LH, Maryland Emerging Infections Program. 2004. Correlating epidemiologic trends with the genotypes causing meningococcal disease, Maryland. Emerg. Infect. Dis. 10:451-456. (Pubitemid 38314471)
18. Harrison LH, Jolley KA, Shutt KA, Marsh JW, O'Leary M, Sanza LT, Maiden MC. 2006. Antigenic shift and increased incidence of meningococcal disease. J. Infect. Dis. 193:1266-1274. http://dx.doi.org/10.1086/501371.
19. Ladhani SN, Lucidarme J, Newbold LS, Gray SJ, Carr AD, Findlow J, Ramsay ME, Kaczmarski EB, Borrow R. 2012. Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009. Emerg. Infect. Dis. 18:63-70. http://dx.doi.org/10.3201/eid1801.110901.
20. Broker M, Jacobsson S, Kuusi M, Pace D, Simoes MJ, Skoczynska A, Taha MK, Toropainen M, Tzanakaki G. 2012. Meningococcal serogroup Y emergence in Europe: update 2011. Hum. Vaccin. Immunother. 8:1907-1911. http://dx.doi.org/10.4161/ hv.21794.
21. European Centre for Disease Prevention and Control. 2013. Annual epidemiological report 2012. Reporting on 2010 surveillance data and 2011 epidemic intelligence data. ECDC, Stockholm, Sweden. http://dx.doi.org/10.2900/ 76137.
22. Serruto D, Bottomley MJ, Ram S, Giuliani MM, Rappuoli R. 2012. The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens. Vaccine 30(Suppl 2):B87-B97. http://dx.doi.org/10.1016/j.vaccine.2012.01.033.
23. Bjune G, Gronnesby JK, Høiby EA, Closs O, Nokleby H. 1991. Results of an efficacy trial with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway. NIPH Ann. 14: 125-130.
24. Caron F, du Chatelet IP, Leroy JP, Ruckly C, Blanchard M, Bohic N, Massy N, Morer I, Floret D, Delbos V, Hong E, Revillion M, Berthelot G, Lemee L, Deghmane AE, Benichou J, Levy-Bruhl D, Taha MK. 2011. From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak. Lancet Infect. Dis. 11:455-463. http://dx.doi.org/10. 1016/S1473-3099(11)70027-5.
25. Brehony C, Jolley KA, Maiden MC. 2007. Multilocus sequence typing for global surveillance of meningococcal disease. FEMS Microbiol. Rev. 31:15-26. http://dx.doi.org/10.1111/j.1574-6976.2006.00056.x. (Pubitemid 46058816)
26. Jolley KA, Kalmusova J, Feil EJ, Gupta S, Musilek M, Kriz P, Maiden MC. 2000. Carried meningococci in the Czech Republic: a diverse recombining population. J. Clin. Microbiol. 38:4492-4498. (Pubitemid 32244539)
27. Maiden MCJ, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, Zhang Q, Zhou J, Zurth K, Caugant DA, Feavers IM, Achtman M, Spratt BG. 1998. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. U. S. A. 95:3140-3145. http://dx.doi.org/10.1073/pnas.95.6.3140. (Pubitemid 28135868)
28. Staden R. 1996. The Staden sequence analysis package. Mol. Biotechnol. 5:233-241. http://dx.doi.org/10.1007/BF02900361. (Pubitemid 126441504)
29. Trotter CL, Chandra M, Cano R, Larrauri A, Ramsay ME, Brehony C, Jolley KA, Maiden MC, Heuberger S, Frosch M. 2007. A surveillance network for meningococcal disease in Europe. FEMS Microbiol. Rev. 31:27-36. http://dx.doi.org/10.1111/j.1574-6976.2006.00060.x. (Pubitemid 46058817)
30. Hunter PR, Gaston MA. 1988. Numerical index of discriminatory ability of typing systems: an application of Simpson's index of diversity. J. Clin. Microbiol. 26:2465-2466.
31. Grundmann H, Hori S, Tanner G. 2001. Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms. J. Clin. Microbiol. 39:4190-4192. http://dx.doi.org/10.1128/JCM.39.11.4190-4192.2001. (Pubitemid 33029810)
32. Robinson DA, Sutcliffe JA, Tewodros W, Manoharan A, Bessen DE. 2006. Evolution and global dissemination of macrolide-resistant group A streptococci. Antimicrob. Agents Chemother. 50:2903-2911. http://dx.doi.org/10.1128/AAC.00325- 06. (Pubitemid 44396391)
33. Dull PM, McIntosh ED. 2012. Meningococcal vaccine development - from glycoconjugates against MenACWY to proteins against MenB: potential for broad protection against meningococcal disease. Vaccine 30(Suppl 2):B18-B25. http://dx.doi.org/10.1016/j.vaccine.2012.01.062.
34. Bambini S, Piet J, Muzzi A, Keijzers W, Comandi S, De Tora L, Pizza M, Rappuoli R, van de Beek D, van der Ende A, Comanducci M. 2013. An analysis of the sequence variability of meningococcal fHbp, NadA and NHBAover a 50-year period in the Netherlands. PLoS One 8:e65043. http://dx.doi.org/10.1371/journal. pone.0065043.
35. Lucidarme J, Comanducci M, Findlow J, Gray SJ, Kaczmarski EB, Guiver M, Vallely PJ, Oster P, Pizza M, Bambini S, Muzzi A, Borrow R. 2010. Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine. Clin. Vaccine Immunol. 17:919-929. http://dx.doi.org/10.1128/CVI.00027-10.
36. Vogel U, Taha MK, Vazquez JA, Findlow J, Claus H, Stefanelli P, Caugant DA, Kriz P, Abad R, Bambini S, Carannante A, Deghmane AE, Fazio C, Frosch M, Frosi G, Gilchrist S, Giuliani MM, Hong E, Ledroit M, Lovaglio PG, Lucidarme J, Musilek M, Muzzi A, Oksnes J, Rigat F, Orlandi L, Stella M, Thompson D, Pizza M, Rappuoli R, Serruto D, Comanducci M, Boccadifuoco G, Donnelly JJ, Medini D, Borrow R. 2013. Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect. Dis. 13:416-425. http://dx.doi.org/10.1016/S1473-3099(13)70006-9.
37. EU-IBIS Network. 2007. Invasive Neisseria meningitidis in Europe 2006. Health Protection Agency, London, United Kingdom.
38. Rosenstein NE, Perkins BA, Stephens DS, Lefkowitz L, Cartter ML, Danila R, Cieslak P, Shutt KA, Popovic T, Schuchat A, Harrison LH, Reingold AL. 1999. The changing epidemiology of meningococcal disease in the United States 1992-1996. J. Infect. Dis. 180:1894-1901. http://dx.doi.org/10.1086/315158.
39. Hellenbrand W, Elias J, Wichmann O, Dehnert M, Frosch M, Vogel U. 2013. Epidemiology of invasive meningococcal disease in Germany, 2002-2010, and impact of vaccination with meningococcal C conjugate vaccine. J. Infect. 66:48-56. http://dx.doi.org/10.1016/j.jinf.2012.09.008.
40. Zhou J, Lefebvre B, Deng S, Gilca R, Deceuninck G, Law DK, De Wals P, Tsang RS. 2012. Invasive serogroup B Neisseria meningitidis in Quebec, Canada, 2003 to 2010: persistence of the ST-269 clone since it first emerged in 2003. J. Clin. Microbiol. 50:1545-1551. http://dx.doi.org/10.1128/JCM.06835-11.
41. Skoczyńska A, Waœko I, Kuch A, Kadłubowski M, Gołêbiewska A, Foryœ M, Markowska M, Ronkiewicz P, Wasiak K, Kozińska A, Matynia B, Hryniewicz W. 2013. A decade of invasive meningococcal disease surveillance in Poland. PLoS One 8:e71943. http://dx.doi.org/10.1371/journal.pone.0071943.
42. Bille E, Ure R, Gray SJ, Kaczmarski EB, McCarthy ND, Nassif X, Maiden MC, Tinsley CR. 2008. Association of a bacteriophage with meningococcal disease in young adults. PLoS One 3:e3885. http://dx.doi.org/10.1371/journal.pone.0003885.
43. Gold R, Goldschneider I, Lepow ML, Draper TF, Randolph M. 1978. Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. J. Infect. Dis. 137:112-121. http://dx.doi.org/10.1093/infdis/137.2.112. (Pubitemid 8289151)
44. Bennett JS, Griffiths DT, McCarthy ND, Sleeman KL, Jolley KA, Crook DW, Maiden MC. 2005. Genetic diversity and carriage dynamics of Neisseria lactamica in infants. Infect. Immun. 73:2424-2432. http://dx.doi.org/10.1128/IAI.73.4. 2424-2432.2005. (Pubitemid 40470845)
45. Caugant DA. 1998. Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS 106:505-525. http://dx.doi.org/10.1111/j.1699- 0463.1998.tb01379.x. (Pubitemid 28308237)
46. Watkins ER, Maiden MC. 2012. Persistence of hyperinvasive meningococcal strain types during global spread as recorded in the PubMLST database. PLoS One 7:e45349. http://dx.doi.org/10.1371/journal.pone.0045349.
47. Yazdankhah SP, Kriz P, Tzanakaki G, Kremastinou J, Kalmusova J, Musilek M, Alvestad T, Jolley KA, Wilson DJ, McCarthy ND, Caugant DA, Maiden MC. 2004. Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J. Clin. Microbiol. 42:5146-5153. http://dx.doi.org/10.1128/JCM.42.11.5146-5153. 2004. (Pubitemid 39506223)
48. Thulin Hedberg S, Toros B, Fredlund H, Olcen P, Molling P. 2011. Genetic characterisation of the emerging invasive Neisseria meningitidis serogroup Y in Sweden, 2000 to 2010. Euro Surveill. 16:pii=19885. http://www.eurosurveillance. org/ViewArticle.aspx?ArticleId=19885.
49. Jounio U, Saukkoriipi A, Bratcher HB, Bloigu A, Juvonen R, Silvennoinen-Kassinen S, Peitso A, Harju T, Vainio O, Kuusi M, Maiden MC, Leinonen M, Kayhty H, Toropainen M. 2012. Genotypic and phenotypic characterization of carriage and invasive disease isolates of Neisseria meningitidis in Finland. J. Clin. Microbiol. 50:264-273. http://dx.doi.org/10. 1128/JCM.05385-11.
50. Fazio C, Neri A, Sofia T, Carannante A, Caporali MG, Salmaso S, Mastrantonio P, Stefanelli P. 2009. Characterisation of Neisseria meningitidis C strains causing two clusters in the north of Italy in 2007 and 2008. Euro Surveill. 14:pii=19179. http://www.eurosurveillance.org/ViewArticle.aspx? ArticleId=19179.
51. Ala'aldeen DA, Oldfield NJ, Bidmos FA, Abouseada NM, Ahmed NW, Turner DP, Neal KR, Bayliss CD. 2011. Carriage of meningococci by university students, United Kingdom. Emerg. Infect. Dis. 17:1762-1763. http://dx.doi.org/10.3201/ eid1709.101762.
52. Jolley KA, Maiden MC. 2010. BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 11:595. http://dx.doi.org/10.1186/1471-2105-11-595.